肺癌药物耐药性中的神秘外体连接
Sambit K Patra1, Rajeev K Sahoo1, Stuti Biswal1
1Cancer Drug Resistance Laboratory, Department of Life Science, National Institute of Technology Rourkela, Odisha 769008, India.
Molecular therapy. Nucleic acids
|April 15, 2024
概括
微小的细胞外囊泡称为外体,通过转移分子和改变瘤微环境,促进肺癌的耐药性. 了解外体的作用是开发新肺癌疗法的关键.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 肺癌带来了重大的治疗挑战,特别是在晚期.
- 药物耐药性是导致治疗失败和肺癌患者预后不良的主要原因.
- 小小的细胞外囊泡,特别是外生体,越来越多地被认为是它们在癌症进展中的作用.
研究的目的:
- 审查外体细胞通过哪些机制调解肺癌中药物耐药性的机制.
- 总结关于外体介导耐药性途径的当前知识.
- 突出外体的潜力作为治疗目标和肺癌的生物标志物.
主要方法:
- 对外体和肺癌中药物耐药性研究的文献综述.
- 在肺癌的背景下对外体生物发生,载荷和功能的分析.
- 综合有关外体介导细胞间通信和微环境调制的信息.
主要成果:
- 外体细胞通过在肺癌细胞之间转移生物分子 (包括信号分子) 来促进细胞间的通信.
- 外体细胞通过促进癌细胞存活和增殖,促进化疗耐药性.
- 外体细胞可以修改瘤微环境,导致表型变化,阻碍药物疗效.
结论:
- 外体细胞通过各种机制在调解肺癌中耐药性的过程中发挥着至关重要的作用.
- 向外体介导通路为针对肺癌的新型治疗策略提供了潜力.
- 对外体功能进行进一步的研究对于开发有效的生物标志物和肺癌治疗方法至关重要.
更多相关视频
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
8.0K
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
8.8K
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
